CG Oncology, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGON and other ETFs, options, and stocks.

About CGON

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). 

CEO
Arthur Kuan
CEOArthur Kuan
Employees
113
Employees113
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2010
Founded2010
Employees
113
Employees113

CGON Key Statistics

Market cap
2.02B
Market cap2.02B
Price-Earnings ratio
-18.98
Price-Earnings ratio-18.98
Dividend yield
Dividend yield
Average volume
1.04M
Average volume1.04M
High today
$26.63
High today$26.63
Low today
$25.73
Low today$25.73
Open price
$26.06
Open price$26.06
Volume
784.71K
Volume784.71K
52 Week high
$40.47
52 Week high$40.47
52 Week low
$14.80
52 Week low$14.80

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%

People also own

Based on the portfolios of people who own CGON. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.